You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
13 November 2026 - Rezolute, Inc. (NASDAQ: RZLT), a late-stage metabolic disease company focused on treating refractory hypoglycemia caused by hyperinsulinism, said preliminary results from a data evaluation show its open-label Phase 3 upLIFT study o...
13 November 2026 - New York-based global type 1 diabetes (T1D) research and advocacy organisation Breakthrough T1D and the Walgreens Foundation announced on Thursday a new national partnership supporting Breakthrough T1D's mission and advancing ...
13 November 2026 - PAI Pharma (PAI), a portfolio company of Olympus Partners and a US-based developer, manufacturer, and marketer of oral liquid medicines and Ready-To-Use (RTU) sterile injectables, announced on Thursday the acquisition of Nexus Phar...
13 November 2026 - Eli Lilly and Company (NYSE: LLY), a US-based pharmaceutical company, broke ground on a USD3.5bn manufacturing facility in Pennsylvania's Lehigh Valley on Thursday.Located in Fogelsville, Pennsylvania, the Lehigh Valley site i...
13 November 2026 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company that develops, manufactures, and commercialises medicines for the treatment of oncology, autoimmune, cardiovascular, and metabolic, ophthalmology, and ...
12 November 2026 - Australian clinical-stage radiopharmaceutical company Clarity Pharmaceuticals Ltd (ASX: CU6) said on Thursday the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to 64Cu-SAR-bisPSMA for PET imagin...
12 November 2026 - MellingMedical, a US-based company that provides veterans with access to healthcare, announced on Wednesday a new strategic relationship with CellTivity Scientific, a US-based company involved in point-of-care disease detection and...